Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?

Did you know that greatly reduced low-density lipoprotein (LDL) receptor activity in homozygous familial hypercholesterolemia (HoFH) leads to severely elevated LDL-cholesterol (LDL-C) levels from birth causing very early onset of cardiovascular disease (CVD) events? Credit available for this activity expires: 3/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000494?ecd=bdc_podcast_libsyn_mscpedu